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The aim was to describe the outcome of neonatal hearing screening (NHS) and audiological diagnosis in neonates in the NICU.
The sample was divided into Group I: neonates who underwent NHS in one step and Group II: neonates who underwent a test and
retest NHS. NHS procedure was automated auditory brainstem response. NHS was performed in 82.1% of surviving neonates. For
GI, referral rate was 18.6% and false-positive was 62.2% (normal hearing in the diagnostic stage). In GII, with retest, referral rate
dropped to 4.1% and false-positive to 12.5%. Sensorineural hearing loss was found in 13.2% of infants and conductive in 26.4% of
cases. There was one case of auditory neuropathy spectrum (1.9%). Dropout rate in whole process was 21.7% for GI and 24.03%
for GII. We concluded that it was not possible to perform universal NHS in the studied sample or, in many cases, to apply it
within the first month of life. Retest reduced failure and false-positive rate and did not increase evasion, indicating that it is a
recommendable step in NHS programs in the NICU. The incidence of hearing loss was 2.9%, considering sensorineural hearing
loss (0.91%), conductive (1.83%) and auditory neuropathy spectrum (0.19%).
1. Introduction
Neonatal intensive care units (NICU) have experienced great
development in the last 20 years. The mortality rate of high-
risk newborn infants has gradually decreased as medical sci-
ence has advanced. In Brazil, recent data revealed increased
incidence of prematurity and low birth weight. One of the
most important health indicators that showed improvement
was the reduction in infant mortality rate [1]. Consequently,
the probability of survival began to reach significant portions
of about threemillion children born every year in the country
[1].
It is known that the same conditions responsible for the
deaths during the neonatal period are the most important
causes of illness of the neonates. Neonatal morbidity asso-
ciated with particularly severe asphyxia, severe infection,
congenital anomalies, and severe respiratory distress results
in delayed death or serious sequels [1]. Newborns who resist
neonatal complications become prone to manifest deviations
in development, including peripheral and/or central hearing
impairment. The incidence of bilateral hearing loss in this
population is estimated at two to five of every 100 newborns,
much higher than that of the low-risk population whose
prevalence is 1 to 3/1000 [2].
Many studies have reported that damage caused by
hearing loss in infancy is often irreversible, affecting not
only the development of speech and language but also the
cognitive, intellectual, cultural, and social child development
[3]. Early acoustic stimulation, especially at sixmonths of age,
leads to increased nerve connections and consequently better
rehabilitation of auditory pathways [4].
Universal neonatal hearing screening (UNHS) is the first
step in a neonatal hearing health program. Itmust be followed
by multidisciplinary care for diagnosis and should be started
as an early intervention process with the use of personal
amplification devices and communication habilitation.
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Risk factors associated with hearing loss were recom-
mended by the Joint Committee on Infant Hearing (JCIH) in
2007 [5]. The use of risk factors is no longer recommended
to select children who should undergo hearing screening.
Studies have shown that only 50% of the pediatric population
with congenital hearing loss would be identified by this
procedure. However, it is essential to identify risk factors for
hearing loss, because an infant with any of these factors in
neonatal history has a greater chance of experiencing hearing
loss. Additionally, it can guide the approach to be adopted
after the results of the hearing screening [6].
JCIH also recommended the use of physiological proce-
dures for screening (EOAE, evoked otoacoustic emissions,
and AABR, automated auditory brainstem response). For
neonates without risk factor for hearing loss (RFHL), any
of the methods are considered appropriate. However, for
neonates with RFHL and especially those who remained in
the NICU, the use of AABR is indicated, considering the
higher occurrence of retrocochlear losses, such as the audi-
tory neuropathy spectrum disorder that cannot be identified
when using EOAE.
For the diagnosis of hearing loss, a protocol with elec-
trophysiologicmeasures, EOAE, tympanometry, and acoustic
reflex testing is recommended. This battery of tests is critical
to determine the type, degree, and configuration of hearing
loss and to guide auditory rehabilitation [7].
The Woman’s University Hospital (CAISM) at State Uni-
versity of Campinas (UNICAMP) is a teaching hospital that
is considered the largest hospital of attention to women’s
health in the state of Sa˜o Paulo, Brazil. The CAISM is
prepared to receive high-risk pregnancies bymaternal and/or
fetal diseases of an extensive region of Sa˜o Paulo totaling
more than 60 counties. The hearing screening procedures
performed at this hospital have been modified over the years.
From the start, the hearing screening program for newborns
admitted to the NICU used AABR, whenever it was possible,
prior to discharge, in a single step. In 2011, new equipmentwas
acquired and in 2012 the retest was introduced. Currently, it
is important to evaluate the results obtained by the program
in order to support its implementation. Thus, the objective
of this research was to evaluate the outcome of the results
in neonatal hearing screening program and audiological
diagnosis in neonates who were hospitalized in the neonatal
intensive care unit.
2. Methods
2.1. Study Design. This is a clinical, prospective, cross-
sectional study. The institutional review board approved this
study (Protocol no. 1085/2009).
The inclusion criteria were neonates who remained in
the NICU from CAISM/Unicamp for at least 48 hours, from
March 2011 to April 2013.
The exclusion criteria were neonates who stayed less than
48 hours in the NICU and those with defects of auricles,
which prevented the performance of AABR, and infants born
in another hospital of the city, who died or who have not
completed all stages of the study.
2.2. Study Subjects. The sample was divided into two groups
according to the date of birth of neonates and hearing
screening procedures:
Group I (GI): neonates born between March 2011 and March
2012 who underwent NHS in one stage;
Group II (GII): neonates born between April 2012 and March
2013, who underwent two-stage NHS (test and retest).
2.3. The Study Procedures. Initially, doctors of the NICU
team selected newborns that could complete the hearing
screening on the days when the screening was performed,
considering the general conditions of the neonate and the
probable date of hospital discharge.Then, identification data,
birth conditions, and risk factors for hearing loss present in
clinical history were collected from medical records and/or
discharge summary of the child (Box 1).
Newborns were screened by an audiologist, using AABR
(Accuscreen, GN Resound) with click-type stimulus on the
intensity of 35 dB NA, preferably before hospital discharge.
When it was not possible, the doctor responsible for the
discharge scheduled the screening.
AABRwas accomplished by placing electrodes, according
to the equipment manual, with white on the top of the
forehead, black on the cheek, and red on the nape of the neck.
An ear probe tip was used in one ear at a time, randomly,
according to the position of the neonate in the cradle or with
the mother in natural sleep. The test result was recorded in
the book of vaccination and/or the newborn medical record.
Infant passed the NHSwhen responding to clicking the 35 dB
bilaterally. In this case, the neonatewas discharged or referred
for follow-up of auditory and language development at 6
months when presenting risk factors associated with delayed-
onset, or progressive hearing loss.
In case of the referred result, the procedureswere different
for groups GI and GII.
Group I: infants were directly referred for complete audiolog-
ical evaluation.
Group II: infants underwent retest with the same initial
screening procedure (AABR), performed in the hospital,
by appointment, approximately one month after discharge.
Newborns who passed the retest were referred for follow-
up of auditory and language development. Those who failed
retest were referred for complete audiological evaluation.
The audiological evaluation was performed at the Lab-
oratory of Diagnostic Audiology Assessment of Children
at Unicamp. The child remained in natural sleep and the
procedures were as follows:
(i) anamnesis with parents and otoscopic exam;
(ii) assessment of the middle ear tympanometry and the
ipsilateral acoustic reflex at 500 to 4000Hz, with a
1000Hz probe tone in infants aged 0 to 6 months and
with a 226Hz in infants older than 6 months, con-
ducted through a Middle Ear Analyzer-Impedance
Audiometer, AT235h, Interacoustics;
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(1) Caregiver concern regarding hearing, speech, language, or developmental delay.
(2) Family history of permanent childhood hearing loss.
(3) Neonatal intensive care of more than 5 days or any of
the following regardless of length of stay: ECMO, assisted ventilation,
exposure to ototoxic medications (gentimycin and tobramycin) or loop
diuretics (furo-semide/Lasix), and hyperbilirubinemia that requires exchange
transfusion.
(4) In utero infections, such as CMV, herpes, rubella, syphilis, and
toxoplasmosis.
(5) Craniofacial anomalies, including those that involve the pinna, ear canal,
ear tags, ear pits, and temporal bone anomalies.
(6) Physical findings, such as white forelock, that are associated with a
syndrome known to include a sensorineural or permanent conductive hearing
loss.
(7) Syndromes associated with hearing loss or progressive or late-onset
hearing loss, such as neurofibro-matosis, osteopetrosis, and Usher syndrome;
other frequently identified syndromes include Waarden-burg, Alport, Pendred,
and Jervell and Lange-Nielson.
(8) Neurodegenerative disorders, such as Hunter syndrome, or sensory motor
neuropathies, such as Friedreich ataxia and Charcot-Marie-Tooth syndrome.
(9) Culture-positive postnatal infections associated with sensorineural hearing
loss, including confirmed bacterial and viral (especially herpes viruses and
varicella) meningitis.
(10) Head trauma, especially basal skull/temporal bone fracture that requires
hospitalization.
(11) Chemotherapy.
Box 1: Risks indicators associated with hearing loss in childhood (JCIH, 2007) [5].
(iii) transient evoked otoacoustic emission (TOAE) cap-
tured by 292 ILO USBII equipment;
(iv) evoked auditory brainstem response (ABR), electro-
physiological threshold and integrity of the auditory
pathway conducted through Eclipse EP 25, Intera-
coustics with insert earphones. The skin was cleaned
with alcohol and an abrasive paste before applying
the conducting gel. Surface electrodes were the active
electrode (Fz) and ground (Fpz) on the forehead,
and the reference electrodes on the right (M2) and
left (M1) mastoids. Impedance between electrodes
was less than 3KOhms, as recommended by the
manufacturer. A nonvariable intensity of 80 dBHL
was used to assess the integrity of auditory pathways
from the inner ear to the brainstem and allowed the
identification of possible changes in this path. The
parameters analyzed were absolute latencies of waves
I, III, and V; latency and interpeaks I-III, III-V, and
I-V; wave V amplitude compared to the amplitude
of wave I; interaural difference in interpeak I-V or
latency of wave V. The electrophysiological threshold
was obtained by the stimulus presented at decreasing
intensities, until the lowest intensity that triggered the
onset of wave V for click (2000 a 4000Hz) and 500
and 1000Hz tone bursts. Stimulation was repeated
twice to check the reproducibility of track and ensure
the presence of response.
It was considered normal hearing when the infant
had lower electrophysiological thresholds/equal to 30 dBHL,
absolute and interpeak within the expected values for ges-
tational age latencies, and responses as expected in other
procedures.
Cases with abnormal results were referred to ENT assess-
ment in the Clinical Hospital of Unicamp and the children
were subjected to physical and/or imaging examination by an
otolaryngologist physician (ENT) team.
The child’s hearing was classified as normal or hearing
loss from the joint analysis of the outcome of audiological
and ENT evaluation. The diagnosis of conductive hearing
loss occurred when the otorhinolaryngological evaluation
revealed disorders of the middle ear by otoscopy associated
with increased values of waves I, III, and V absolute latencies
and normal I-III, III-V, and I-V interpeaks, plus no transient
or distortion product otoacoustic emissions, tympanogram
type B or C, and no acoustic reflex. Sensorineural hearing
loss was diagnosedwhenwaves I, III, andV absolute latencies
and I-III, III-V, and I-V interpeaks were normal or there
was absence of wave I and prolongation of latencies of
waves III and V or total absence of waves, depending on
the degree of the hearing loss. Moreover, this diagnostic
included electrophysiological thresholds greater than 30 dB,
no TOAE, tympanometry type A, and presence or absence
of acoustic reflexes, according to the degree of loss. The
auditory neuropathy spectrum was characterized by absence
of responses on ABR at the maximum intensity of the
device (100 dB), presence of cochlear microphonic, presence
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of TOAE, tympanogram type A, and no ipsilateral acoustic
reflexes.
All data collected in the child’s records, as well as the
results obtained by the hearing screening and other assess-
ments performed, were recorded in a computerized database.
Tables of the results were constructed. To compare groups I
and II regarding qualitative characteristics, Chi-square test
or Fisher exact test was applied. The same tests were used to
study the outcome of the hearing screening and audiological
diagnosis for GI and GII. To assess the risk of hearing loss
according to the presence of risk factors, the prevalence ratio
and its confidence interval were calculated. The significance
level was 5%; data in which statistically significant differences
were found are highlighted in bold.The SAS software version
9.2 was used for this analysis.
3. Results
The study sample consisted of 929 live newborns, 52.5%
male, 66.1% preterm births, and 42.7% underweight (weight
between 1500 and 2500 g).
TheGI consisted of 488 newborns (NB) andGII consisted
of 441NB. There were no statistical difference between GI
and GII and the variables gender (𝑃 = 0.44), gestational age
(𝑃 = 0.91), and birth weight (𝑃 = 0.85), which gave the group
homogeneity.
Figure 1 presents the NHS procedure (test and retest,
audiological and ENT diagnosis) in GI and GII.
Table 1 shows a comparison of the results obtained in the
NHS for GI-test and GII-test and retest.
Table 2 presents the results related to ENT and audiolog-
ical diagnosis, for GI and GII. The incidence of hearing loss
can be observed in Table 3.
In Table 4, we studied the period the NHS performed on
days after birth and postconceptual age inweeks, aswell as the
relationship between the outcome of the NHS and the period
in which it was performed.
Table 5 shows evasion in hearing screening and audiolog-
ical diagnostics processes for studied groups.
Table 6 presents the frequency of risk factors of infants
who underwent hearing screening, step test (𝑛 = 763).
It was found that the risk factor related to craniofacial
anomalies involving the ear and temporal bone significantly
influenced the outcome of the NHS test (𝑃 < 0.0001), retest
(𝑃 < 0.0078), and the audiological diagnosis (𝑃 < 0.0431).
Neonates with this indicator showed a greater number of
failures in hearing screening test and retest, and also in the
diagnosis of hearing loss compared to normal hearing and
conductive loss compared to sensorineural.
The risk factors for birth weight less than 1500 g, prema-
turity, neonatal and congenital infections, and anoxia were
studied linked because they are frequent in newborns from
NICU. It was verified that they did not affect the outcome
of the NHS (𝑃 = 0.0598). In this case, the diagnosis of
normal hearing was more frequent when compared with
the diagnosis of hearing loss (𝑃 = 0.0236). The statistical
difference also occurred when comparing the type of hearing
Table 1: Infants from the GI and GII, considering the results of the
newborn hearing screening.
NHS GI-test GII-test and retest 𝑃 value∗
𝑛 % 𝑛 %
Pass 337 81.4% 324 95.9%
<0.0001
Refer 77 18.6% 14 4.1%
∗Chi-square test/Fisher exact test.
loss, with the most common being the conductive type (𝑃 =
0.0425).
The results showed higher failure rate in neonates with
genetic syndromes that usually express hearing loss, both in
GI (𝑃 < 0.0001) and in GII in the retest (𝑃 = 0.0011).
The only neonate who presented the diagnosis of neonatal
asphyxia showed sensorineural hearing loss.
4. Discussion
Neonatal hearing screening is the main mode for early
detection of hearing loss. The procedure should be fast and
simple and select those most likely to have an alteration in
auditory function [6]. The use of AABR is recommended as
a screening procedure, which evaluates the auditory system
up to the brainstem structures, and is practical and easy to
apply [5]. The equipment uses clicks stimulus, does not allow
visualization of the waves, and automatically sends PASS or
REFER response. It is a method with high sensitivity (ability
of the test to identify hearing loss) and specificity (ability
to identify the individual listener as normal), Hall et al. [8].
Some studies indicate median specificity by considering the
rare upward losses that are not identified by the method,
besides conductive loss.
Hearing screening was performed in 82.1% of 929 live
births that remained in the NICU for more than 48 hours
(Figure 1). We intended to perform universal hearing screen-
ing as recommended by JCIH [5]. However, some factors
made it impossible to reach the index of greater than or
equal to 95% of children screened. Due to a large demand
for admissions in the NICU from CAISM, newborns in
better condition but not eligible for hospital discharge yet are
often transferred to other health services. This particularity
of service prevented the hearing screening before hospital
discharge in all cases transferred due to interference of the
equipment that the child still had to use in the hearing
screening procedure. Furthermore, inmany cases, the screen-
ing was not recommended because the newborn was taking
ototoxic medications or other treatments that should be kept
after the transfer and that could affect the auditory system
and therefore modify the results of the hearing screening.
These cases were scheduled for further hearing screening
in CAISM, since many hospitals that receive transferred
neonates lack the hearing screening service. However, many
of these cases did not show up, even after a second contact.
Frequent absences also occurred in cases of neonates who
were discharged mainly on weekends, when the screening
service was not available. Associated with these factors, the
family’s lack of awareness about the importance of returning
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Sensorineural
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Figure 1: Flowchart of NHS test and retest and audiological and ENT diagnosis.
for hearing screening and lack of resources for going to the
service, among other factors, could also have contributed to
the absences.
Several international studies have reached index of cov-
erage greater than or equal to 95% and were the ones who
conducted the hearing screening especially before hospital
discharge [9–12]. Brazilian studies showed coverage rates
between 69% and 90% [13, 14]. Some studies compared
the results in NHS when it was performed before hospital
discharge or after discharge (immunization clinics, e.g.) and
showed coverage of approximately 88% [15, 16]. In this study,
the coverage was similar to research reports that also had to
schedule the NHS, because it was not possible to screen all
neonates before hospital discharge.
On the global scene, the UNHS was recommended by
the United States Preventive Services Task Force [17] and
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Table 2: Infants from the GI and GII, considering the ENT and audiological diagnosis.
Diagnosis Group I Group II Total 𝑃 value∗
𝑛 % 𝑛 % 𝑛 %
Normal 28 62.2% 1 12.5% 29 54.7%
0.0098
Conductive 9 20.0% 5 62.5% 14 26.4%
Sensorineural 6 13.3% 1 12.5% 7 13.2%
ANSD∗∗ 1 2.2% 0 0% 1 1.9%
Death 1 2.2% 1 12.5% 2 3.8%
Total 45 100% 8 100% 53 100
∗∗ANSD: auditory neuropathy spectrum disorder/∗Fisher exact test.
Table 3: Infants from GI and GII considering the incidence of hearing loss.
Hearing loss Group I Group II Total
𝑛 % 𝑛 % 𝑛 %
Conductive 9/414 2.2% 5/349 1.4% 14/763 1.8%
Sensorineural 6/414 1.44% 1 0.3% 7/763 0.91%
ANSD 1/414 0.24% 0 0% 1/763 0.13%
Total 16/414 3.9% 6 1.7% 22/763 2.9%
EuropeanConsensus Statement onNeonatalHearing Screen-
ing [15] in 2008. In several countries, NHS is widespread,
while in others it is considered a very expensive process and
its value is questionable [16].
In developing countries, the challenges are greater. The
high birth rate associated with the high prevalence of hearing
loss combined with frequent exposure to risk factors makes
the coverage of UNHS more difficult [18]. In addition, there
is a poor health system parallel to insufficient funding. Many
countries have already recognized the importance of early
detection of hearing loss, but there was not a chance to make
it universal in national terms yet. Generally the screening
occurs in isolated services with varying results.
Thus, to increase the number of screened newborns
and achieve coverage greater than 95% it is recommended,
whenever possible, that NHS be performed prior to hospital
discharge, which minimizes missing schedules and hence
increases the quality of care and cost benefit of the program.
Another factor that may improve adherence to NHS is
the guidance to health professionals and the families of
newborns, focusing on the importance of hearing for the
development of speech and language, the explanations about
the NHS, its role in early detection of hearing loss, and the
importance of attending the service to perform the scheduled
date of the hearing test.
Most children who performed hearing screening resulted
in passing bilaterally, as the observed response to clicks on the
AABR was found at 35 dB (Figure 1).
When comparing the results obtained in the NHS
between GI and GII, we found a significant difference
between the results. In GII-test and retest, there was a 4.1%
rate of referral, whereas in the GI-test, the referral occurred
in 18.6% of infants (Table 1). Thus, the retest decreased
to 4% refer rate, as recommended by the committees and
reduced the dropout rate for the diagnosis. Consequently, it
was possible to reduce unnecessary referrals and minimize
stress, distress and parental anxiety related to income hearing
screening. The reduced rates obtained in the literature are
based on two stages of NHS-test and retest [19, 20]. There are
studies that performed more than one testing before hospital
discharge, which further reduced failure rates [21].
In our research, infants who failed underwent the step
of diagnosis. In GI, otorhinolaryngological and audiological
diagnostics showed that of all children who completed
the procedure, 62.2% (28 cases) presented normal hearing.
Hearing loss occurred in 35.5% (16) of infants of which 20.0%
(9 cases) were conductive, 13.6% (6 cases) sensorineural, and
2.2% (1 case) with auditory neuropathy spectrum disorder
(Figure 1). In GI, there was a high rate of false positives,
because most infants who underwent diagnosis evaluation
presented normal results.
In GII, normal hearing occurred in 12.5% of cases. The
hearing loss occurred in 75%of children, of which 62.5%were
conductive and 12.5% sensorineural. Comparing these results
with the groups, it was found that there was a significant
difference (Table 2). In GII, there were fewer infants with
normal hearing and greater relative number of infants with
hearing loss than the GI. The retest decreased the false
positive in GII and most children who failed the retest
presented hearing loss.
The incidence of hearing loss in the sample was approx-
imately 3%, of which 0.91% were sensorineural, 0.13% with
auditory neuropathy spectrum disorder (ANSD), and 1.8%
conductive (Table 3). The high incidence in the literature
refers to sensorineural hearing loss normally. In neonates that
remained in NICU, values ranged from 0.8% to 4.9% [19, 22–
25], which is consistent with our findings.The same occurred
for the results obtained with the ANSD, the incidence of
which can vary from 0.1% to 4% [26–28]. The conductive
hearing loss was the most frequent in this study. It must
be analyzed and identified due to its significant presence
and negative interference in language development of the
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Table 4: Infants from the GI and GII, which held the NHS first test considering the time in days after birth and postconceptual age, in weeks,
in which hearing screening was applied and the result passed and failed.
Hearing screening
GI GII
Referral Pass 𝑃 value Referral Pass 𝑃 value
𝑛 % 𝑛 % 𝑛 % 𝑛 %
Time after birth (days) 0.1805 <0.0001
<30 49 63.6 198 59.1 28 59.6 187 65.6
≥30 a < 60 10 13.0 74 22.1 0 0.0 52 18.2
≥60 18 23.4 63 18.8 19 40.4 46 16.1
Postconceptual age 0.1713∗ 0.7343∗
<30 0 0.0 0 0.0 0 0.0 1 0.4
≤30 a < 34 0 0.0 1 0.3 0 0.0 8 2.8
≤34 a < 37 19 24.7 92 27.5 9 19.1 95 33.3
≥37 58 75.3 242 72.2 38 80.9 181 63.5
∗Chi-square test/Fisher exact test.
Table 5: Infants from the GI and GII, considering the dropout rate in the various stages of NHS and audiological diagnosis.
Stages Group I Group II 𝑃 value∗
𝑛 % 𝑛 %
NHS-first stage 74/488 15.2% 92/441 20.9%
0.4012NHS-retest — — 9/441 2.04%
Diagnosis 32/488 6.55% 6/441 1.360%
Total 106/488 21.7% 106/441 24.03%
∗Chi-square test.
child.Moreover, it can complicate the diagnosis of permanent
hearing loss [13].
The most common etiology is otitis media, clinical entity
characterized by acute inflammation of the mucosal lining of
the middle ear. It is the most frequent diagnosis in children
and becomes less common with advancing age. Children
presented 65% of risk of developing an episode during the
first 24 months. Otitis media is considered a highly prevalent
disease in childhood, with higher peak incidence between
6 and 24 months of age, and the second peak incidence
between 4 and 7 years old. Inflammation of the middle
ear cavity results from the interaction of several factors.
The most important factors are infection and auditory tube
dysfunction, which result from immaturity of the immune
system and also the structural and functional immaturity of
the auditory tube [29]. Although otitis media is a floating
condition that often affects one ear and usually causes mild
hearing loss, it is clearly associated with major limitations in
the development of language and speech. These children will
be accompanied by professional staff, because it is already
proven interference from conductive hearing loss in auditory
and language development and future academic performance
[30].
The cases of sensorineural hearing loss are in habilitation
(hearing aids or cochlear implant) and speech rehabilitation
process. Paludetti et al. [31] considered the rehabilitation
as the most challenging management of sensorineural loss.
The current procedures are represented by hearing aids and
cochlear implants indication. However, recent advances in
the basic area can represent the basis for new therapeutic
procedures such as implantable device, brainstem implant,
and cellular therapy.
The ANSD occurred in one neonate from GI, who
was born at 38 weeks of gestational age and 3175 g of
weight, remained 55 days in NICU, and presented the risk
factors neonatal asphyxia and mechanical ventilation for
prolonged periods, which were the probable etiology of the
alteration.The infant refer NHS bilaterally on AABR to 45 dB
and diagnosis showed no waves in the ABR, presence of
cochlear microphonic and otoacoustic emissions, tympano-
metric curve type A, and no acoustic reflex. A study realized
with temporal bones of preterm revealed 27% of selective loss
of inner hair cells, higher prevalence than term infants (41%
versus 28%) [32]. The infant was referred for indication and
fitting of hearing aids and/or cochlear implants and speech
therapy.
The results of NHS were analyzed, step test, considering
the age in days after birth and postconceptual age at which
screening was applied and the results passed or referred
(Table 4). It was found that around 60% of children who
passed the NHS in both GI and GII underwent a hearing
screening within 30 days of life. A shorter residence in the
neonatal intensive care unit assumed less severe cases, faster
recovery of prenatal, perinatal and postnatal complications,
and shorter use of specialized equipment and/or drug treat-
ment. These conditions caused less damage to the auditory
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Table 6: Infants who underwent hearing screening, step test, considering the frequency of each risk (𝑛 = 763).
Risk factors 𝑛 %
Family history of permanent childhood hearing loss 7 0.9
Birth weight less than 1500 g 153 20.1
Preterm birth 508 66.8
Neonatal intensive care of more than 5 days 537 70.6
Assisted ventilation 279 36.7
Exposure to ototoxic medications or loop diuretics 239 31.4
Hyperbilirubinemia that requires exchange transfusion 42 5.5
Craniofacial anomalies 22 2.9
Severe perinatal anoxia 44 5.8
In utero infections (CMV, herpes, rubella, syphilis, and toxoplasmosis) 43 5.7
Syndromes associated with hearing loss 15 2.0
Neurodegenerative disorders 3 0.4
Culture-positive postnatal infections associated with sensorineural hearing loss 7 0.9
Head trauma 2 0.3
Chemotherapy 1 0.1
system and consequently more children passed the NHS.
Therewere neonateswhounderwent a hearing screeningwith
more than 30 days of life, due to a prolonged stay in theNICU.
None of the infant GI or GII with postconceptual age less
than 34 weeks failed the NHS, so the postconceptual age did
not influence the results ofNHS.The literature recommended
that NHS conducted through AABR be applied from 34
weeks so there is no influence of the maturity of the auditory
system, especially up the brainstem, in the pass/fail result
[33]. The findings of this study are consistent with the
literature that shows that the NHS should be performed as
soon as possible, considering only the clinical condition of the
infant, and unnecessary delay of the NHS should be avoided
[34].
Children who passed, but presented risk indicators for
progressive and/or late hearing loss, were referred for hearing
and language follow-ups at 6, 12, 18, and 24 months. This
procedure also aimed to detect any upward or conductive
losses that, given the characteristics of procedure adopted,
passed the NHS. The literature indicated that the follow-
ups conducted in infants in the NICU showed that hearing
deteriorated in a small percentage of children [34]. It was
diagnosed progressive or late onset hearing loss in children
followed until the age of three with less than 28 weeks of
gestational age and weighing less than 1250 g [35].
The dropout at various stages of NHS and audiologi-
cal diagnosis was computed. No significant difference was
found between evasion in different stages for GI and GII.
Considering the screening, stage test, and diagnostic in
GI, dropout was 21.7%. In the retest performed in GII,
dropout was 2% and, considering the whole process, about
24% (Table 5). Therefore, dropout was not affected by retest
applied in GII. In the study performed by Korres et al.
[36], the retest decreased the false positive but increased
evasion. In addition, to further reduce the evasion rate, it is
necessary to implement a system for search and follow-up of
cases, humanized assistance, and elaboration of educational
materials to families.
The evasion of hearing care programs is a global reality.
States with programs of early detection and intervention
more developed in the United States include prevalence
2-3/1000 infants with hearing loss, but there are states with
lower prevalence, probably due to dropout. In the United
States, only 55.2% of children who failed the hearing screen-
ing attended diagnosis and 64.3% are in rehabilitation pro-
grams [16, 23]. Evasion for the diagnosis ranged from 1.73%
to 81.25%. For the retest, dropout values ranged from 23.1%
to 62% [24, 36, 37]. Reduced dropout rate of 1.73% [38]
was obtained as a result of good communication between
professionals who had made the screening and diagnosis;
besides all children had received a letter with the failed result.
Adherence to hearing health programs is a challenge that
must be overcome in order to achieve the goals of early
detection of hearing loss. The low attendance at prenatal
consultations (one to three visits), having more than one
child in the family, the absence of a partner, in addition
to low maternal education, lack or low number of available
services, and lack of knowledge of responsible membership
interfered in the adhesion in child health program [23].
Socioeconomic factors can have a significant influence on the
effectiveness of NHS programs in low-income countries [14].
It was recommended that the prenatal consultation issues
concerning the importance of hearing in child development
and the real possibility of early detection of hearing loss
should be addressed in order to introduce new elements for
mothers’ reflection about childhood hearing loss and their
damage. The importance of the NHS should also be dissem-
inated among health professionals, especially pediatricians,
accompanying infants systematically during routine visits
and could encourage the return to service until the conclusion
of the TAN and reinforce the importance of early detection of
hearing loss on child development.
Themost common risk factors in the studied sample were
NICU patients who stayed for more than 5 days, preterm
birth, use of mechanical ventilation, being small for gesta-
tional age, exposure to ototoxic drugs, weight of less than
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1500 g, and Apgar score of 0–4 in the first minute (Table 6).
These results were expected, since the sample consisted of
newborns who required intensive care and remained at least
48 hours in NICU and/or intermediate care. In Bielecki et al.
[39] study, ototoxic medication was the most common risk
factor, followed by premature birth, low birth weight, and
long admittance in ICU. Severe asphyxia and mechanical
ventilation were more frequent in Hille et al. study [40].
It was found that craniofacial anomalies involving the
ear and temporal bone significantly influenced the outcome
of the hearing screening and audiological diagnosis.Neonates
with this indicator showed a greater number of failures in the
hearing screening, diagnosis of hearing loss compared to nor-
mal hearing, and conductive loss in relation to sensorineural.
We compared the results obtained in hearing screening
and audiological diagnosis of neonates who had at least one
indicator of the risk factors, including birth weight less than
1500 g, preterm birth, anoxia neonatal, and congenital infec-
tions with the results of neonates who presented the other
studied risk factors. This analysis was conducted because
they are often present in clinical histories of newborns that
remained in theNICU. It has been found that these indicators
did not influence the result of hearing screening. Comparing
the diagnosis of normal hearing and hearing loss, there
was a significant difference, with normal hearing the most
frequent result. The statistical difference also occurred when
comparing the type of hearing loss; the most frequent was
conductive hearing loss.
Genetic syndromes that usually express hearing loss
significantly influenced the result of NHS, step test for GI
and GII and retest stage for GII, resulting in higher failure
rate in neonates with this factor. GI andGII preterm neonates
showed a lower percentage of referral than the others in the
test stage. The risk indicator neonatal asphyxia influenced
the diagnosis. The only neonate with this indicator showed
sensorineural hearing loss.
Comparing our results with the literature, it was verified
that low birth weight, mechanical ventilation, and growth
retardation were significantly associated with reference to
NHS, unlike our findings [12]. Literature studies also found
a significant relationship between hearing loss and the risk
factors: neonatal asphyxia [23, 35], syndromes associated
with hearing loss [23], and craniofacial anomalies [23].
Craniofacial anomalies had a significant relationship with
conductive hearing loss [11], as in this study.
It is essential to consider the risk factors present in
the clinical history of newborns, not to select candidates
for hearing screening, but to serve as a guide to the most
appropriate management for each case. It is imperative that
infants with risk indicators that influenced the results of the
hearing screening and diagnosis of hearing loss attend the
necessary steps of the hearing child health program.
5. Conclusion
From the analysis of the results the following was concluded.
(i) It was not possible to perform universal neonatal
hearing screening in the sample. The postconceptual
age did not influence the result of hearing screening;
therefore, it should not be unnecessarily delayed.
It should be performed as soon as possible, only
considering the clinical condition of the infant.
(ii) Retesting reduced the failure rate, the rate of false
positives and did not interfere with dropout, so it
is a recommendable stage in ICU hearing screening
programs.
(iii) The incidence of hearing loss was 2.9%, considering
sensorineural hearing loss, conductive hearing loss,
and auditory neuropathy spectrum. The incidence of
sensorineural hearing loss was 1.04%.
(iv) Strategies to minimize the evasion in child hearing
health programs should be implemented.
(v) Infants with craniofacial anomalies involving the
ear and temporal bone showed a higher number of
failures in the hearing screening of hearing loss diag-
nosis compared to normal hearing and of conductive
loss in relation to sensorineural. The risk factors of
genetic syndromes that often express hearing loss and
prematurity had significant influence on the outcome
of hearing screening.
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